Sarepta's FDA decision date; Flare gets Anna Protopapas as CEO

June 30, 2026 10:43 AM EDTUpdated 11:43 AM News Briefing Sarep­ta's FDA de­ci­sion date; Flare gets An­na Pro­topa­pas as CEO ENDPOINTS Plus news about Deer­field, In­flaRx, Prax­is, Nu­vec­tis, Pyx­is On­col­o­gy, Vista­gen, Ar­cutis Bio­ther­a­peu­tics and Nx­era. 🔎 FDA to de­cide on fu­ture of Sarep­ta ex­on-skip­ping drugs by … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER